Ali Jazayeri
Research Subjects
Ali Jazayeri has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Alastair J.H. Brown
Sosei Heptares, Steinmetz Building, Granta Park, Great Abington, Cambridge CB21 6DG, United Kingdom
1 shared publication- Andrea Bortolato
SandboxAQ
1 shared publication - Argyris Politis
The University of Manchester
1 shared publication - Asma H. Baig
Brunel University London, Centre for Pollution Research and Policy, College of Health, Medicine and Life Sciences, Kingston Lane, Uxbridge, UB8 3PH, UK
1 shared publication Benjamin Gerald Tehan
OMass Therapeutics, Oxford, United Kingdom
1 shared publication- Carol Vivien Robinson
Kavli Institute for Nanoscience Discovery, Dorothy Crowfoot Hodgkin Building, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- Open Access
- 2 May 2025
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 92, 103051
The evolving role of hydrogen/deuterium exchange mass spectrometry in early-stage drug discovery
- 2 May 2025
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 92, 103051
Open AccessThe evolving role of hydrogen/deuterium exchange mass spectrometry in early-stage drug discovery
- Open Access
- 10 November 2022
- Published by Springer Nature in Nature Chemistry
- Vol. 14 (12) , 1375-1382
Mass spectrometry captures biased signalling and allosteric modulation of a G-protein-coupled receptor
G-protein-coupled receptors signal through cognate G proteins. Despite the widespread importance of these receptors, their regulatory mechanisms for G-protein selectivity are not fully understood. Here we present a native mass spectrometry-based approach to interrogate both biased signalling and allosteric modulation of the β1-adrenergic receptor in response to various ligands. By simultaneously capturing the effects of ligand binding and receptor coupling to different G proteins, we probed the relative importance of specific interactions with the receptor through systematic changes in 14 ligands, including isoprenaline derivatives, full and partial agonists, and antagonists. We observed enhanced dynamics of the intracellular loop 3 in the presence of isoprenaline, which is capable of acting as a biased agonist. We also show here that endogenous zinc ions augment the binding in receptor–Gs complexes and propose a zinc ion-binding hotspot at the TM5/TM6 intracellular interface of the receptor–Gs complex. Further interrogation led us to propose a mechanism in which zinc ions facilitate a structural transition of the intermediate complex towards the stable state.
- 10 November 2022
- Published by Springer Nature in Nature Chemistry
- Vol. 14 (12) , 1375-1382
Open AccessMass spectrometry captures biased signalling and allosteric modulation of a G-protein-coupled receptor
G-protein-coupled receptors signal through cognate G proteins. Despite the widespread importance of these receptors, their regulatory mechanisms for G-protein selectivity are not fully understood. Here we present a native mass spectrometry-based approach to interrogate both biased signalling and allosteric modulation of the β1-adrenergic receptor in response to various ligands. By simultaneously capturing the effects of ligand binding and receptor coupling to different G proteins, we probed the relative importance of specific interactions with the receptor through systematic changes in 14 ligands, including isoprenaline derivatives, full and partial agonists, and antagonists. We observed enhanced dynamics of the intracellular loop 3 in the presence of isoprenaline, which is capable of acting as a biased agonist. We also show here that endogenous zinc ions augment the binding in receptor–Gs complexes and propose a zinc ion-binding hotspot at the TM5/TM6 intracellular interface of the receptor–Gs complex. Further interrogation led us to propose a mechanism in which zinc ions facilitate a structural transition of the intermediate complex towards the stable state.
- 1 October 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (20) , 126611
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure-based drug design
- 1 October 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 29 (20) , 126611
Identification of a novel allosteric GLP-1R antagonist HTL26119 using structure-based drug design